Promising findings for therapeutic hepatitis C vaccine TG4040
Depression and pegylated interferon: doctors look at screening strategies and treatment
Black race and depression associated with poorer adherence to HIV treatment
Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS
Unplanned treatment interruptions involve a greater risk of virological failure than missing occasional doses
Poor knowledge of HIV PrEP among MSM in Beijing, but high interest
Only 20% of US HIV-positive people have high levels of engagement with specialist HIV care
Unmet basic subsistence needs is the most important factor affecting health of poor HIV-positive men
Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity
![Josep Llovet, University of Barcelona [Photo by Liz Highleyman, hivandhepatitis.com]](https://ik.imagekit.io/ftwmbwg7i/tr:w-640,h-480,q-80,fo-auto,f-auto/https%3A%2F%2Fcdn.craft.cloud%2F019ecfe4-fa59-7378-875f-6ad629d65a81%2Fassets%2F2012-04%2Fbrivanib-did-not-improve-overall-liver-cancer-survival-but-did-show-anti-tumour-activity.jpg?ik-s=72da0bc390c58f9e219054c2b59b14a731faf359&ik-t=7552444800)